Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/15/23 18:55 | 9/19/23 | NMRA | Health | BioPrd | Biological Products, (No Diag | Burow Kristina | IL | DT | 7 | P.dm | 31,430 | 15.66 | 0 | 2,007 | 15 | 15,525 | M | |||||||||||||||
11/15/23 18:54 | 11/13/23 | NMRA | Health | BioPrd | Biological Products, (No Diag | Arch Venture Partners Xii, LLC | IL | T | 6 | P.m | 5,930 | 11.69 | 0 | 507 | 14 | 4,131 | I | |||||||||||||||
9/20/23 06:16 | 9/19/23 | NMRA | Health | BioPrd | Biological Products, (No Diag | Arch Venture Partners X, LLC | IL | T | 2 | P.d | 51,000 | 17.00 | 0 | 3,000 | 11 | 29,545 | I | |||||||||||||||
9/19/23 21:47 | 9/19/23 | NMRA | Health | BioPrd | Biological Products, (No Diag | Gosebruch Henry O | MA | DO | P,CEO | 1 | P | 189 | 12.62 | 0 | 15 | 3 | 525 | I | ||||||||||||||
9/19/23 19:52 | 9/19/23 | NMRA | Health | BioPrd | Biological Products, (No Diag | Amgen Inc | CA | T | 1 | P.d | 30,000 | 17.00 | 0 | 1,765 | 5 | 35,369 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |